BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23819368)

  • 1. [Metastatic micropapillary variant of urothelial carcinoma of the urinary bladder responding to gemcitabine and cisplatin chemotherapy].
    Ishii T; Matsubara T; Taira H; Hiratsuka Y
    Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):540-4. PubMed ID: 23819368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of undifferentiated bladder carcinoma with axilla lymph node metastasis successfully treated with gemcitabine and cisplatin].
    Takayanagi N; Chiba H; Sagawa T; Hirayama Y; Tsuji Y; Sakamaki S
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2137-40. PubMed ID: 14712779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metastases of Urothelial Carcinoma with Trophoblastic Differentiation that Responded to Combination Chemotherapy with Gemcitabine and Oxaliplatin : A Case Report].
    Uchida M; Kawai K; Kurobe M; Ikeda A; Kandori S; Endo T; Miyagawa T; Kojima T; Tsutsumi M; Nishiyama H
    Hinyokika Kiyo; 2018 Feb; 64(2):55-61. PubMed ID: 29684950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of small cell carcinoma in the urinary bladder responding to gemcitabine/cisplatin combination therapy as neoadjuvant chemotherapy].
    Shirato A; Shimamoto K; Ozawa A; Tanji N; Yokoyama M
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2097-9. PubMed ID: 17197762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma].
    Inoue T; Ohyama C; Horikawa Y; Togashi H; Matsuura S; Tsuchiya N; Satoh S; Sato K; Habuchi T; Saito S; Hoshi S; Arai Y; Kato T
    Hinyokika Kiyo; 2004 Apr; 50(4):273-7. PubMed ID: 15188623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durable complete remission of metastatic sarcomatoid carcinoma of the bladder with cisplatin and gemcitabine in an 80-year-old man.
    Froehner M; Gaertner HJ; Manseck A; Wirth MP
    Urology; 2001 Nov; 58(5):799. PubMed ID: 11711370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report.
    Kojima Y; Takahi Y; Ichimaru N; Okumi M; Takahara S; Nonomura N
    BMC Res Notes; 2015 Feb; 8():25. PubMed ID: 25648269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic agents, chemotherapy, and the treatment of metastatic transitional cell carcinoma.
    Vogelzang NJ
    J Clin Oncol; 2013 Feb; 31(6):670-5. PubMed ID: 23341524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
    Siefker-Radtke AO; Dinney CP; Shen Y; Williams DL; Kamat AM; Grossman HB; Millikan RE
    Cancer; 2013 Feb; 119(3):540-7. PubMed ID: 22914978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micropapillary variant of transitional cell carcinoma of the bladder.
    Sugino Y; Negoro H; Iwamura H; Moroi S; Oka H; Kawakita M; Hanioka K; Takeuchi H
    Int J Urol; 2004 Sep; 11(9):792-4. PubMed ID: 15379948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
    Pfister C; Gravis G; Fléchon A; Soulié M; Guy L; Laguerre B; Mottet N; Joly F; Allory Y; Harter V; Culine S;
    Eur Urol; 2021 Feb; 79(2):214-221. PubMed ID: 32868138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on chemotherapy in the treatment of urothelial carcinoma.
    Costantini C; Millard F
    ScientificWorldJournal; 2011; 11():1981-94. PubMed ID: 22125450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Combination Therapy of Gemcitabine Plus Paclitaxel Induced Complete Response in a Tongue Skin Brain Metastasis of Bladder Carcinoma: A Case Report].
    Uemura Y; Ushida H; Ishitoya S; Onishi H; Terashima T; Takeuchi E
    Hinyokika Kiyo; 2015 Oct; 61(10):405-9. PubMed ID: 26563624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin].
    Ishii M; Yamamoto Y; Yoshimura A; Hayashi T; Kawamura N; Nagahara A; Nakai Y; Nakayama M; Nishimura K
    Hinyokika Kiyo; 2023 Apr; 69(4):107-112. PubMed ID: 37183041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.
    Hussain M; Daignault S; Agarwal N; Grivas PD; Siefker-Radtke AO; Puzanov I; MacVicar GR; Levine EG; Srinivas S; Twardowski P; Eisenberger MA; Quinn DI; Vaishampayan UN; Yu EY; Dawsey S; Day KC; Day ML; Al-Hawary M; Smith DC
    Cancer; 2014 Sep; 120(17):2684-93. PubMed ID: 24802654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of diffusion-weighted MRI in monitoring response of lymph node metastatic bladder cancer treated with chemotherary].
    Nakayama T; Yoshida S; Fujii Y; Koga F; Saito K; Masuda H; Kobayashi T; Kawakami S; Kihara K
    Nihon Hinyokika Gakkai Zasshi; 2008 Nov; 99(7):737-41. PubMed ID: 19068691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report.
    Ohtaka M; Kawahara T; Kumano Y; Maeda Y; Kondo T; Mochizuki T; Ishida H; Hattori Y; Teranishi J; Miyoshi Y; Yumura Y; Yao M; Inayama Y; Uemura H
    J Med Case Rep; 2016 Mar; 10():48. PubMed ID: 26951070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.
    Dash A; Pettus JA; Herr HW; Bochner BH; Dalbagni G; Donat SM; Russo P; Boyle MG; Milowsky MI; Bajorin DF
    Cancer; 2008 Nov; 113(9):2471-7. PubMed ID: 18823036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study.
    Necchi A; Lo Vullo S; Raggi D; Perrone F; Giannatempo P; Calareso G; Togliardi E; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Colecchia M; Busico A; Pennati M; Zaffaroni N; Mariani L; Salvioni R
    Urol Oncol; 2018 Jan; 36(1):8.e1-8.e8. PubMed ID: 28911922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder.
    Scosyrev E; Messing EM; van Wijngaarden E; Peterson DR; Sahasrabudhe D; Golijanin D; Fisher SG
    Cancer; 2012 Jan; 118(1):72-81. PubMed ID: 21720989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.